Concepedia

Qingcong Lin

QL

Statistics

Publications

15

Citations

1.1K

H-Index

15

Active since

2000

Affiliations

Harvard University(Current)

Pfizer (United States)

Mass General Brigham

Albert Einstein College of Medicine

Massachusetts General Hospital

Qingcong Lin is an author at Harvard University specializing in life sciences, genetics, and medicine.

Publications per year

2000–2017

15

Publications

15

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway

Hong Zhao, Yuming Guo, Shu Li et al. · Oncotarget · 2015 · 154 citations · Full text

, , +17

Onset of Abnormal Blood and Lymphatic Vessel Function and Interstitial Hypertension in Early Stages of Carcinogenesis

Jeroen Hagendoorn, Ricky T. Tong, Dai Fukumura et al. · Cancer Research · 2006 · 136 citations · Full text

, , +17

Normal Spermatogenesis in Mice Lacking the Testis-Specific Linker Histone H1t

Qingcong Lin, Allen Sirotkin, Arthur I. Skoultchi · Molecular and Cellular Biology · 2000 · 133 citations · Full text

, , +17

Mammalian linker-histone subtypes differentially affect gene expression <i>in</i> <i>vivo</i>

Raouf Alami, Yuhong Fan, Stephanie Pack et al. · Proceedings of the National Academy of Sciences · 2003 · 109 citations · Full text

, , +17

Participation of mouse DNA polymerase ι in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer

Chad A. Dumstorf, Allan Clark, Qingcong Lin et al. · Proceedings of the National Academy of Sciences · 2006 · 103 citations · Full text

, , +16

1–5 of 15